Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureAbstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cardiovascular toxic effects of targeted cancer therapies
10.1056/nejmra1100265 · 2016
Myocardial protection during cardiotoxic chemotherapy
10.1161/circulationaha.114.010486 · 2015
An oral selective alpha-1A adrenergic receptor agonist prevents doxorubicin cardiotoxicity
2017
Developmental regulation of mitochondrial apoptosis by c-Myc governs age- and tissue-specific sensitivity to cancer therapeutics
10.1016/j.ccell.2016.11.011 · 2017
Type II chemotherapy-related cardiac dysfunction: time to recognize a new entity
10.1200/jco.2005.05.827 · 2005
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
10.1016/j.echo.2014.07.012 · 2014
No additional external references are available.